
SisterLove Inc is a 32-year-old sexual reproductive health rights and justice organization with a core focus on HIV and sexually transmitted infections at the intersection of other challenges to women's sexual reproductive health and well-being.

SisterLove Inc is a 32-year-old sexual reproductive health rights and justice organization with a core focus on HIV and sexually transmitted infections at the intersection of other challenges to women's sexual reproductive health and well-being.

The combined toll of the COVID-19 pandemic and the health effects of climate change tests an already beleaguered US health system.

A new report finds roughly three-quarters of patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis used painkillers, although biologics appear to curb the need for nonsteroidal anti-inflammatory drugs, in particular.

FDA reportedly aims to fully approve Pfizer-BioNTech COVID-19 vaccine by early next month; Biogen’s Alzheimer drug sees little uptake; majority of Americans over 65 have received at least 1 dose of a COVID-19 vaccine.

The Association of Community Cancer Centers’ (ACCC’s) annual survey on immuno-oncology (IO) therapies highlighted major concerns among health care providers regarding financial impacts, education, and access to clinical trial data.

Investigators of a 3-year observational study identified independent risk factors for exacerbations related to chronic obstructive pulmonary disease (COPD) and successfully developed a novel risk score for COPD exacerbations.

August is National Psoriasis Awareness Month, and on this episode of Managed Care Cast, we bring you an excerpt of an interview with a New Jersey dermatologist about the changing concept of psoriasis as more than just a skin disease.

The pandemic has exacerbated not only cardiovascular care, but also the mental health of patients, noted Mariana Garcia, MD, cardiology fellow in the Academic Clinical Investigator Pathway at Emory University and member of T32, Multidisciplinary Research Training to Reduce Inequalities in Cardiovascular Health (METRIC).

Identifying patients with combined polypharmacy and frailty can help recognize ICU patients with high risk of hospital readmission, the authors said.

People with high risk of obstructive sleep apnea presented with significant changes in key arteries indicative of accelerated vascular aging, a known contributor to cardiovascular disease (CVD).

A report reviews the case of a patient with stage IV melanoma who, while having several issues with treatment toxicity, was later free of disease following treatment with BRAF and MEK inhibitors.

Survey data found that better diagnosis and treatment methods are needed among patients with chronic cough in Japan due to the prevalent nature of the condition.

Seventy percent of Americans have received at least 1 dose of a COVID-19 vaccine; CMS releases payment rules for fiscal year 2022; alcohol linked to over 700,000 new cancer diagnoses in 2020.

A significant risk of neurodegenerative disease was found in an analysis of male former professional soccer players, with defensive outfield players and those with careers longer than 15 years particularly at risk.

The study was conducted to shed more light on the growing issue of polypharmacy, an issue that is expected to increase as the US population ages.

The cumulative effects of binge drinking and HIV on neurocognitive functioning were investigated among 4 groups of patients in this recent study from researchers at San Diego State University and the University of California San Diego.

Patient-reported outcome measures may have a small impact on predicting which patients with cirrhosis will be readmitted to the hospital.

Results of an observational study suggest retinal nerve fiber layer atrophy and the presence of oligoclonal bands may serve as biomarkers for cognitive decline in patients with multiple sclerosis (MS).

Results of a cross-sectional study point to a potential link between iron intake and migraine that may be dependent on age.

David McIntyre, MD, FRACP, outlines how metabolic factors could impact the severity of COVID-19 infections among pregnant people.

Florida sets record for daily COVID-19 cases and hospitalizations; spotlighting health equity in the workplace; delineating COVID-19 hotspots where masking is recommended.

Leslie Eiland, MD, outlines some of the challenges of delivering optimal care to patients with type 1 diabetes (T1D) living in rural America.

New research shows central obesity is associated with an increased risk of poor heart failure outcomes among those with type 1 diabetes.

Peer support nursing intervention produced significant benefits in lung function and quality of life (QOL) in patients with chronic obstructive pulmonary disease (COPD), highlighting the importance that nurses can play in improving disease management.

The latest news in rheumatology includes the need for robust vaccinations in juvenile idiopathic arthritis; new findings about rheumatoid arthritis (RA) and type 2 diabetes; and quality of life in systemic lupus erythematosus.

On World Lung Cancer Day, we explore current guidelines for lung cancer screening in the United States, implications of the COVID-19 pandemic, and disparities in mortality and access to care by race and socioeconomic status.

Gary Lyman, MD, MPH, an oncologist and hematologist, discusses how financial incentives, concerns for patients, and interchangeability impact biosimilar prescribing patterns.

In an interim analyses of the phase 3 SEQUOIA trial, zanubrutinib had superior progression-free survival compared with bendamustine plus rituximab in patients with treatment-naive chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL).

Drug optimization in older adults improved outcomes in this retrospective study.

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, discusses the process of cataract development and its prevalence in both older and younger populations.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
